IL140032A0 - New use of a pyridazinone derivative - Google Patents

New use of a pyridazinone derivative

Info

Publication number
IL140032A0
IL140032A0 IL14003299A IL14003299A IL140032A0 IL 140032 A0 IL140032 A0 IL 140032A0 IL 14003299 A IL14003299 A IL 14003299A IL 14003299 A IL14003299 A IL 14003299A IL 140032 A0 IL140032 A0 IL 140032A0
Authority
IL
Israel
Prior art keywords
new use
pyridazinone derivative
treatment
pyridazinyl
acetamide
Prior art date
Application number
IL14003299A
Other languages
English (en)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL140032A0 publication Critical patent/IL140032A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL14003299A 1998-06-19 1999-05-26 New use of a pyridazinone derivative IL140032A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/099,945 US5905078A (en) 1998-06-19 1998-06-19 Use of a pyridazinone derivative
PCT/FI1999/000449 WO1999066932A1 (en) 1998-06-19 1999-05-26 New use of a pyridazinone derivative

Publications (1)

Publication Number Publication Date
IL140032A0 true IL140032A0 (en) 2002-02-10

Family

ID=22277351

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14003299A IL140032A0 (en) 1998-06-19 1999-05-26 New use of a pyridazinone derivative
IL140032A IL140032A (en) 1998-06-19 2000-12-01 New use for the consequence of pyridazinone

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140032A IL140032A (en) 1998-06-19 2000-12-01 New use for the consequence of pyridazinone

Country Status (18)

Country Link
US (2) US5905078A (de)
EP (1) EP1087769B1 (de)
JP (1) JP4938928B2 (de)
AT (1) ATE261305T1 (de)
AU (1) AU760379B2 (de)
BR (1) BR9911237A (de)
CA (1) CA2334910C (de)
CZ (1) CZ295283B6 (de)
DE (1) DE69915475T2 (de)
EE (1) EE04658B1 (de)
ES (1) ES2217767T3 (de)
HU (1) HUP0202836A3 (de)
IL (2) IL140032A0 (de)
NZ (1) NZ508444A (de)
PL (1) PL194344B1 (de)
SK (1) SK285004B6 (de)
TR (1) TR200003772T2 (de)
WO (1) WO1999066932A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
EP1833480A2 (de) * 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Kardiotonische verbindungen mit hemmwirkung gegen beta-adrenerge rezeptor und phosphodiesterase
AR068814A1 (es) 2007-08-29 2009-12-09 Orion Corp Composicion farmaceutica que comprende levosimendan y un inhibidor de la enzima conversina de la angiotensina (ace), y uso
WO2011027021A1 (en) 2009-09-01 2011-03-10 Orion Corporation A method for the treatment of hypertension
US8418825B2 (en) 2010-10-28 2013-04-16 Ford Global Technologies, Llc Magnetically actuated mechanical diode
US9366298B2 (en) 2010-10-28 2016-06-14 Ford Global Technologies, Llc Magnetically actuated clutch assembly
US9915301B2 (en) 2010-10-28 2018-03-13 Ford Global Technologies, Llc Magnetically actuated mechanical diode
CA3145456A1 (en) 2019-07-01 2021-01-07 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746712A (en) * 1971-06-08 1973-07-17 A Ross 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JPS588015A (ja) * 1981-07-06 1983-01-18 Mitsubishi Chem Ind Ltd 強心剤
JP2921933B2 (ja) * 1989-07-14 1999-07-19 帝国臓器製薬株式会社 光学活性酪酸誘導体
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
JP3163050B2 (ja) 1997-12-25 2001-05-08 三洋電機株式会社 自動洗髪機

Also Published As

Publication number Publication date
DE69915475T2 (de) 2005-03-24
AU760379B2 (en) 2003-05-15
EP1087769B1 (de) 2004-03-10
JP2002518450A (ja) 2002-06-25
DE69915475D1 (de) 2004-04-15
EE04658B1 (et) 2006-08-15
CZ20004554A3 (en) 2001-05-16
CZ295283B6 (cs) 2005-06-15
CA2334910C (en) 2007-10-23
SK285004B6 (sk) 2006-04-06
WO1999066932A1 (en) 1999-12-29
JP4938928B2 (ja) 2012-05-23
NZ508444A (en) 2003-03-28
CA2334910A1 (en) 1999-12-29
IL140032A (en) 2007-05-15
EE200000755A (et) 2002-04-15
ES2217767T3 (es) 2004-11-01
HUP0202836A2 (hu) 2003-02-28
PL194344B1 (pl) 2007-05-31
TR200003772T2 (tr) 2001-06-21
HUP0202836A3 (en) 2003-03-28
PL345036A1 (en) 2001-11-19
US5905078A (en) 1999-05-18
EP1087769A1 (de) 2001-04-04
USRE38102E1 (en) 2003-04-29
ATE261305T1 (de) 2004-03-15
SK18732000A3 (sk) 2001-12-03
AU4516699A (en) 2000-01-10
BR9911237A (pt) 2001-03-06

Similar Documents

Publication Publication Date Title
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
DK199801679A (da) Præparat samt kit til brug ved intraoculære operationer
DK2143420T3 (da) Formulering, der omfatter mutant(er) af lysosomal alfa-galactosidase A, til behandling af Fabrys sygdom
ES2115163T3 (es) Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis.
NO971520L (no) Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
MY112973A (en) Methods for inhibiting vascular smooth muscle cell migration
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
IL140032A0 (en) New use of a pyridazinone derivative
DE59308848D1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
DK0988302T3 (da) Benzonaphthyridiner
EA199800019A1 (ru) Способ повышения плотности кальциевых каналов
SE9101840L (sv) Ny medicinsk anvaendning
MX9709466A (es) Medicamento para inhibir el melanoma.
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
DK0659082T3 (da) Anvendelse af cytochrom P450 inhibitorer til inhibering af metabolismen af nitrogensubstituerede acridiner
EE04355B1 (et) Levosimendani kasutamine kopsuhüpertensiooni ravimi tootmises
EA200001098A1 (ru) Пероральные композиции с контролируемым высвобождением левозимендана
SE9802538D0 (sv) New pharmaceutically active compounds
MX9701333A (es) Metodos para inhibir el daño neuronal.
CO5070658A1 (es) Agentes terapeuticos utiles para el tratamiento y prevencion de enfermedades cardio vasculares en mujeres posmenopausi- cas
SE9404438D0 (sv) New process
ATE350101T1 (de) Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens
HRP20080389A2 (en) THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed